Toward next-generation hip implants: From failure mechanisms to translational design Authors: Yunhua Luo, Thomas Turgeon, Ian Polyzois Published: 2026 ABSTRACT AbstractTotal hip replacement (THR) is highly successful in restoring mobility after hip fracture, yet long-term complications such as aseptic loosening, periprosthetic fracture, wear-induced osteolysis, and stress shielding continue to limit implant longevity. These failure modes largely originate from the inability of monolithic implant designs to satisfy the heterogeneous mechanical and biological requirements of the proximal femur. Their uniform material properties and fixed architecture hinder physiological load transfer, compromise osseointegration, and accelerate bone loss. Functionally graded hip scaffold–implant hybrids (FG-HSIHs) have emerged as a promising next-generation solution, offering spatial control over stiffness, porosity, degradation behavior, and surface bioactivity within a single construct to better mimic the structure and function of healthy bone.This review synthesizes advances in clinical understanding, biomechanics, mechanobiology, and computational modeling relevant to the development of FG-HSIHs. We first examine the biological pathways and biomechanical mechanisms underlying major THR complications, highlighting the inherent conflicts among desired material and structural properties. These mechanistic insights form the basis for simulation-guided strategies that enable spatially adaptive design tailored to mitigate specific failure risks. We then evaluate current progress in mechanical modeling, mechanobiological simulation, multiphysics analysis, and multi-objective optimization, and assess how these components contribute to an integrated design workflow. Despite rapid progress, no existing framework fully unifies mechanical, biological, transport, and degradation processes or incorporates patient-specific biological factors. Key challenges remain in defining physiologically grounded grading targets, establishing predictive validation pipelines, and implementing multiphysics-driven design tools suitable for translational use. Overall, the purpose of this review is to assemble a coherent, field-wide perspective on the clinical, biomechanical, biological, and computational considerations relevant to FG-HSIH design, rather than cataloging all technical details.Translational potential of this articleThe framework presented in this review provides a structured pathway for translating functionally graded hip scaffold–implant hybrids from concept to clinically testable prototypes. By linking THR failure mechanisms with biomechanical requirements, biological pathways, and computational design strategies, the review identifies actionable targets for implant innovation and preclinical development. The synthesis of mechanical modeling, mechanobiology, and multiphysics optimization offers a roadmap for generating designs that more effectively integrate with host bone and reduce long-term revision risk. The identified translational gaps—including the lack of integrated mechanobiological–degradation models, limited patient-specific biological inputs, and insufficient validation pipelines—clarify priorities for future experimental studies, preclinical testing protocols, and multidisciplinary collaboration. Collectively, these insights support the development of next-generation hip implants that can improve long-term patient outcomes and reduce the burden of revision surgery.Keywords: Total hip replacement, Long-term failure modes, Scaffold–implant hybrid, Functionally graded materials, Integration of mechanical and biological needs, Multiphysics simulation, Simulation-guided design optimization Introduction Hip fractures represent one of the most serious skeletal injuries, particularly among the elderly population, and are associated with substantial morbidity, reduced quality of life, and elevated mortality [[1], [2], [3]]. Globally, the annual incidence of hip fractures is projected to exceed 6 million cases by 2050 due to aging populations and increasing rates of osteoporosis [4]. These injuries often require surgical intervention, with total hip replacement (THR) being the standard treatment option. While current THR technologies have significantly improved short-term outcomes, long-term implant survivability and osseointegration remain major clinical concerns [5]. Conventional hip implants are typically made of monolithic metallic materials, such as titanium or cobalt–chromium alloys, engineered to provide high mechanical strength and wear resistance. However, these implants often fail to replicate the mechanical and biological characteristics of native bone. One of the most critical complications is aseptic loosening, often initiated by stress shielding [6,7]—a condition where the stiffness mismatch between the implant and surrounding bone leads to bone resorption and implant instability [8,9]. In addition, the biological inertness of many metallic implant materials impedes osseointegration, delaying healing and increasing the risk of revision surgery [10,11]. Other prevalent failure mechanisms include mechanical fatigue, periprosthetic fracture, and micromotion-induced fibrous tissue formation at the bone–implant interface [12,13]. These issues are exacerbated in patients with poor bone quality or comorbidities such as diabetes and rheumatoid arthritis [14]. Continuous efforts have been made to improve implant design to overcome these limitations [[15], [16], [17]], as illustrated by the evolution of hip implant design shown in Fig. 1. Early-generation implants were predominantly solid metallic structures (e.g., stainless steel, CoCr, titanium), which provided high strength and wear resistance but often resulted in stress shielding. Among subsequent developments, trabecular metal implants and porous tantalum components demonstrate excellent osteoconductivity and mechanical compatibility due to their high porosity, reduced effective elastic modulus, and interconnected pore networks that facilitate bone ingrowth [[18], [19], [20]]. In parallel, additively manufactured porous titanium stems enable precise control of lattice architecture and porosity, thereby improving load transfer and reducing stiffness mismatch with host bone [21,22]. These approaches represent significant advances over conventional monolithic designs by partially addressing mechanical-biological integration challenges; however, they primarily optimize individual properties in isolation rather than achieving coordinated, multi-functional performance across the implant as a whole [23,24]. Consequently, despite advances in specific aspects such as surface coatings, porous architectures, and additive manufacturing, long-term complications persist, largely because current designs remain limited in their ability to balance competing requirements for mechanical performance, biological compatibility, and long-term stability. Brief evolution history of hip implant design. These challenges underscore the need for next-generation hip implant designs that move beyond monolithic constructs and instead mimic the spatial and functional complexity of native bone. In particular, the inability of current implants to simultaneously meet region-specific mechanical and biological requirements has driven a shift toward functionally graded and biomimetically engineered solutions. One promising approach is the development of functionally graded hip scaffold–implant hybrid (FG-HSIH). The emerging FG-HSIH concept builds upon these developments by extending beyond single-property optimization toward a spatially integrated, multi-property design framework, in which stiffness, porosity, degradation behavior, and surface bioactivity are coordinated across different regions of the implant. This perspective provides a natural progression in the evolution of hip implant design, from homogeneous materials to porous structures and toward fully functionally graded systems that aim to simultaneously address mechanical and biological requirements [25,26]. Such multifunctional integration is particularly critical in hip fracture cases, where compromised bone quality and complex loading conditions render the host bone—rather than the implant itself—more susceptible to long-term failure. FG-HSIH is increasingly explored as a promising next-generation concept in orthopedic engineering. Advances in additive manufacturing, biomaterials engineering, and computational modeling now provide the tools needed to design, fabricate, and evaluate these complex graded systems. In particular, additive manufacturing (3D printing) has accelerated the development of FG-HSIH by enabling precise control over internal architecture and material distribution. 3D printing offers unparalleled flexibility in fabricating implants with complex geometries, gradient porosity, and multi-material configurations that would be impossible to achieve with conventional manufacturing methods [26,27]. While additive manufacturing offers these advantages, its fatigue performance remains a major concern compared with conventionally manufactured materials, such as those produced by casting and forging. Nevertheless, emerging technologies—including defect-tolerant design, advanced post-processing, in situ monitoring, and non-destructive evaluation—are steadily improving reliability and narrowing the gap with conventionally manufactured implants [[28], [29], [30]]. Since numerous review papers have already addressed 3D printing technologies for biomedical applications (for example, [31]), this review does not aim to duplicate those efforts. Instead, this review focuses on mechanistic analyses of long-term failure modes, integrative simulations coupling mechanical and biological processes in the bone–implant system, and paradigm-shifting design strategies for functionally graded scaffold–implant hybrids in hip fracture repair—irrespective of the specific 3D printing method. It should be noted that the concept of FG-HSIH presented in this work is currently conceptual in nature. This article is therefore intended as a conceptual and perspective review, aiming to synthesize existing knowledge and propose a forward-looking, integrative design framework, rather than to describe a clinically established implant system. The objective is to provide a structured foundation for future research and development by linking clinical failure mechanisms with emerging advances in biomaterials, biomechanics, and computational design. Section 2 begins with a detailed analysis of the most prevalent failure modes and their underlying mechanisms in current hip implants, establishing the clinical and biomechanical motivations for developing FG-HSIH. Section 3 introduces the concept, architecture, and design variables of FG-HSIH and explains, in a mechanistic view, how spatial gradation of stiffness, porosity, degradation behavior, and bioactivity can mitigate the root causes of long-term implant failure. Section 4 analyzes the intrinsic trade-offs among mechanical and biological design parameters and discusses strategies for balancing competing requirements to achieve optimal performance. Section 5 presents an integrated, simulation-guided design framework for FG-HSIH, synthesizing recent advances in image-based assessment, finite-element analysis, biological and multiphysics simulations, and multi-objective optimization. Section 6 identifies clinical indications and connects them with design synthesis, and concludes with remaining challenges and future directions toward a predictive and clinically translatable design platform. Long-term failure modes in current hip implants: mechanistic and causal insights Understanding failure mechanisms and their underlying causes is essential for advancing the design of hip implants. Among all types of hip fractures, femoral neck fractures pose the greatest clinical challenges due to their anatomical complexity and the simultaneous demand for mechanical stability and biological integration [32]. These fractures are also the most prevalent, particularly in the elderly population, accounting for approximately 45–55% of all hip fracture cases [33]. Total hip replacement (THR) is commonly used to treat femoral neck fractures and is considered among the most complex orthopedic devices due to the diverse functional requirements they must fulfill [25,34]. As shown in Fig. 2, THR design imposes particularly complex—and often conflicting—functional requirements. Mechanically, the articulation between the acetabular cap and the femoral head must allow for smooth rotation; the femoral neck must withstand high cyclic bending loads during daily activities; and the femoral stem must achieve stable fixation within the host proximal femur. Biologically, the implant must promote rapid and robust osseointegration at the bone–implant interface to ensure long-term stability, while minimizing adverse responses such as inflammation, fibrous encapsulation, or osteolysis. These demands are further intensified by the disruption of intracapsular vascularity caused by femoral neck fracture, as this region already has limited blood supply, thereby hindering natural bone healing and remodeling. Illustration of a total hip replacement system. (a) The prosthetic implant components, including the acetabular shell, femoral head, neck, and femoral stem. (b) The total hip implant integrated within the pelvic and femoral anatomy, showing placement and articulation at the hip joint. Due to these complexities, and despite its widespread short-term clinical success, total hip replacement remains susceptible to long-term complications that frequently lead to revision surgery [35]. These failure modes typically result from a multifactorial interplay involving suboptimal implant design, adverse material–tissue interactions, biomechanical mismatches, and the host's biological response. A mechanistic, cause-based understanding of these complications is essential for developing more durable, mechanically compatible, and biologically integrated implant designs. As illustrated in Fig. 3, we investigate the three most common long-term failure modes [[36], [37], [38]]—aseptic loosening, periprosthetic fractures, and implant fatigue failures—using a bottom-up approach. It should be noted that the relationships among root causes, biological mechanisms, and failure modes are inherently many-to-many rather than one-to-one. We begin with the prevalence of these failure modes, trace their progression back through the underlying biological mechanisms, and identify the mechanical and material causes that can be addressed through improved implant design. Hierarchical relationship among failure modes and underlying causes in total hip replacements. Common long-term failure modes influenced by implant design Aseptic loosening is the gradual failure of the bond between an implant and bone in the absence of infection, typically caused by mechanical instability and biological reactions to wear particles that lead to bone resorption [39]. Aseptic loosening remains the leading cause of revision surgery following total hip arthroplasty, accounting for approximately 52–66% of all revision cases in recent registries and cohort studies [38,40]. Periprosthetic fractures are bone fractures that occur around or near an orthopedic implant [12,41] and are often associated with trauma, implant loosening, or weakened bone quality. Periprosthetic femoral fractures are increasingly recognized as a serious and growing complication following total hip arthroplasty [14,42], particularly among elderly and osteoporotic patients whose bone quality is compromised. Implant fatigue failure is the structural fracture of an orthopedic implant caused by the accumulation of microdamage under repeated cyclic loading over time [43,44], often occurring in areas of stress concentration or material weakness. Fatigue fractures of THR—most often involving the femoral neck—can result in sudden and acute structural failure, frequently necessitating urgent revision surgery [45,46]. It should be noted that, although implant design critically influences long-term success, a substantial proportion of revisions result from factors beyond design control—such as instability and dislocation [47], adverse local tissue reactions and metallosis [48], and periprosthetic joint infection [49]—which are closely related to surgical techniques and biological responses and are therefore not addressed in this paper. Biological mechanisms underlying design-amenable long-term failure modes Having identified the failure modes affected by implant design, it is important to understand how they develop over time. This requires tracing their progression back through the biological responses that unfold at the implant–bone interface. By examining the cellular and molecular mechanisms underlying each failure mode, we can identify the biological and mechanical processes that contribute to implant instability, bone degradation, or mechanical failure—thereby linking clinical outcomes to their root causes. Among the three design-amenable failure modes identified in Section 2.1, implant fatigue fracture is most directly linked to material limitations, with biological processes playing a minimal role in the failure of conventional hip implant materials. The biological mechanisms underlying the other two failure modes—aseptic loosening and periprosthetic fractures—are more complex and do not follow a simple one-to-one relationship with clinical outcomes. As detailed in the following paragraphs, the literature identifies three biologically mediated and mechanically relevant pathways that represent the primary links between the root causes and clinical failure, as illustrated in Fig. 3: (i) wear-particle–induced osteolysis, (ii) mechanically driven adaptive bone resorption due to stress shielding and sustained micromotion, and (iii) poor osseointegration arising from insufficient surface bioactivity and/or interface instability. The following paragraphs examine how each pathway progresses from early cellular signaling to structural consequences, ultimately contributing to aseptic loosening and, in some cases, predisposing the bone to periprosthetic fracture. Wear-particle–induced osteolysis is widely recognized as a key biological driver of both aseptic loosening and periprosthetic fracture following total hip arthroplasty (THA) [50]. At the cellular level, phagocytosis of polyethylene, metal, or ceramic debris by macrophages initiates a sustained inflammatory response, characterized by the release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), chemokines, and growth factors [51,52]. These mediators promote osteoclast differentiation and activation through the RANKL–RANK pathway and NF-κB signaling, resulting in pathological bone resorption at the bone–implant interface [53,54]. Recent studies have expanded this understanding by implicating additional immune cell types—including T and B lymphocytes and mast cells—in perpetuating the inflammatory milieu and enhancing osteolytic activity [13,55]. Working together, these molecular and cellular mechanisms undermine both cortical and cancellous bone integrity, ultimately leading to aseptic loosening and increasing the risk of periprosthetic fracture. Bone resorption is the physiological process by which osteoclasts remove bone, balanced under normal conditions by osteoblastic formation. Around implants, mechanically driven imbalances can push this process into a pathological state [39,56]. Initially, adverse mechanical conditions—specifically stress shielding (mechanical underloading) and sustained interface micromotion (discussed in the next subsection)—disrupt osteocyte mechanotransduction [57,58], perturb interstitial fluid pressures, and, via altered osteocytic signaling, promote osteoclast recruitment and activation [59,60]. Osteocytes amplify this response by shifting the local RANKL/OPG balance (e.g., via sclerostin-mediated signaling), thereby favoring resorption over formation [57,59]. Unlike wear-particle–driven osteolysis (which is fundamentally inflammatory), this alternative pathway is governed by mechanical underloading and strain-adaptive remodeling. Over time, regions of the femur that receive reduced load can undergo site-specific thinning of cortical and trabecular bone, undermining bone–implant interlock and gradually destabilizing fixation. Poor osseointegration arises when the peri-implant environment is suboptimal due to mechanical instability (e.g., inadequate initial fixation, micromotion) or adverse biology (e.g., insufficient surface bioactivity/biocompatibility or debris-driven inflammation) [10,11,13]. Rather than re-describing the inflammatory cascade, we refer to wear-particle–induced osteolysis as the principal inflammatory route that inhibits osteoblast activity and promotes osteoclastogenesis [13,61,62]. Functionally, failure to achieve stable bone–implant contact permits micromotion, encourages fibrous encapsulation, and progressively weakens anchorage, predisposing to aseptic loosening and, in vulnerable bone, periprosthetic fracture. Accordingly, successful osseointegration depends not only on limiting pathological resorption/osteolysis but also on the design of implant materials and geometries that support biological integration under physiological loading [63]. Design-related root causes For the biological mechanisms of implant failure discussed in Section 2.2—namely osteolysis, pathological bone resorption, and poor osseointegration—it is crucial to trace them back to the underlying mechanical and material factors that initiate or exacerbate these adverse responses. A substantial body of literature [[6], [7], [8],64,65] has shown that stress shielding, surface wear, micromotion at the bone–implant interface, and material limitations are the primary root causes that trigger or amplify these processes, as illustrated in Fig. 3. These biological mechanisms are therefore best understood as downstream consequences of underlying mechanical or material deficiencies, most of which arise from suboptimal implant design. Understanding the relationships between these root causes and their biological outcomes is critical for guiding future improvements in implant design. In the remainder of this subsection, each root cause and its associated biological response is analyzed based on evidence reported in the literature. Stress shielding has been consistently identified as a key mechanical factor contributing to periprosthetic bone loss in total hip arthroplasty [6,7,64,66,67]. For materials commonly used in conventional hip implants, the elastic modulus of cobalt–chromium alloys typically ranges from 210 to 230 GPa [68,69], while Ti-6Al-4V alloys exhibit values of around 110 GPa [70,71], and medical-grade ceramics (e.g., alumina, zirconia) exceed 300 GPa [72]. In contrast, cortical bone in the human femur only has an elastic modulus of 10–30 GPa, while trabecular bone often exhibits values below 2 GPa [73,74]. This large mismatch diverts mechanical stress away from the surrounding bone, diminishes the mechanical stimulation of osteocytes, and disrupts the tightly regulated remodeling balance governed by Wolff's law, thereby tipping bone turnover towards resorption rather than formation. In response, osteoclast activity becomes upregulated in regions deprived of mechanical load, accelerating localized bone resorption and cortical thinning. Over time, these losses in bone density accumulate, contributing to osteolysis—particularly when combined with wear particles that further stimulate osteoclast-mediated bone degradation. Concurrently, the absence of sufficient mechanical stimuli suppresses osteoblastic function, impairing new bone formation and weakening bone–implant integration. Surface wear occurs at the intended articulation—the femoral head–acetabular liner interface—in metal–polyethylene or ceramic–polyethylene pairings. In contrast, micromotion at the stem–bone contact is unintended, small-amplitude relative motion under physiological loading. Both processes generate particulate debris; as detailed in Section 2.2, this debris initiates inflammatory cascades that drive osteolysis, bias remodeling toward bone resorption, and impair osseointegration [[51], [52], [53], [54],75]. The cumulative effect is progressive periprosthetic bone loss, ultimately leading to aseptic loosening or periprosthetic fracture—patterns that are consistently associated with an increased risk of revision surgery [50,76]. Material limitations in hip implants represent a broad domain of concern, encompassing issues such as fatigue failure. The previously discussed root causes—mechanical property mismatch and wear debris generation—also fall within this category. Additional challenges include inadequate biocompatibility, insufficient surface bioactivity, and suboptimal interfacial chemistry, as extensively documented in the literature [8,69,[77], [78], [79], [80]]. Rather than cataloging each limitation individually, we emphasize the unifying constraint: no single monolithic material can simultaneously meet the conflicting mechanical and biological demands of a hip implant over time, a theme elaborated further in Section 3. Even when general biocompatibility standards are satisfied, conventional hip implant materials—such as cobalt–chromium alloys, titanium alloys (e.g., Ti-6Al-4V), and ceramics—retain inherent shortcomings that manifest as deeper mechanical complications, including stress shielding, surface wear, and micromotion at the bone–implant interface, as outlined in preceding sections. Despite many incremental advances, conventional hip implants remain fundamentally incapable of eliminating the causal pathways of long-term failure. Their uniform, single-material architecture cannot spatially reconcile competing functional demands, so residual mechanisms—micromotion, stress shielding, debris-induced osteolysis, and interface instability—persist and erode longevity. This intrinsic limitation of homogeneous materials underscores the need to transition toward functionally graded scaffold–implant hybrids. Functionally graded hip Scaffold–Implant hybrids: A promising solution This section focuses on the potential of functionally graded hip scaffold–implant hybrid (FG-HSIH) to address the failure mechanisms associated with conventional hip implants and materials. Specifically, we (1) define the concept and architecture, identify key design variables of FG-HSIH, and (2) explain, from a mechanistic perspective, how spatial grading of stiffness, porosity, degradation behavior, and bioactivity mitigates the previously identified root causes of failure, while reviewing state-of-the-art advances that enable FG-HSIH development. Architecture of functionally graded Scaffold–Implant hybrids A hip scaffold–implant hybrid (HSIH), as illustrated in Fig. 4(a), is an advanced hip prosthesis concept that integrates a permanent load-bearing implant region (comprising the femoral neck and head), a scaffold-like stem region designed to gradually integrate with and be replaced by natural bone tissue, and a transition zone connecting these two regions. Such a HSIH design is more effective than conventional monolithic, homogeneous implants and standalone scaffolds in treating hip fractures, potentially offering improved long-term success. Traditional implants, typically manufactured from uniform, high-stiffness alloys, often cause stress shielding, poor load sharing, and long-term bone resorption, as evidenced by studies reviewed in the previous section. In contrast, standalone scaffolds can promote bone ingrowth and remodeling but typically lack the immediate load-bearing capacity and long-term durability required for hip joint function, and thus have not been widely adopted for hip implants. By integrating a permanent load-bearing region with a scaffold region capable of gradual bone replacement, the hybrid provides immediate structural stability while promoting biological integration and natural bone regeneration over time. Illustration of a functionally graded hip scaffold–implant hybrid. (a) Structural configuration highlighting three distinct regions: a permanent implant region, a scaffold-like stem, and an intermediate transition zone. (b) Functional gradation of stiffness across the device. To enhance long-term performance, the HSIH concept incorporates functional grading of mechanical and biological properties. Functional grading refers to the spatial variation of material properties (e.g., stiffness) and microstructural features (e.g., porosity, pore size, and architecture) to meet region-specific requirements across a scaffold–implant hybrid, enabling smooth transitions between zones that replicate corresponding bone or tissue functions. Using stiffness as an example, Fig. 4 (b) illustrates how stiffness is graded across the device. The femoral neck and inner core of the femoral head exhibit high stiffness to provide structural support under physiological loading. The stem is designed with reduced stiffness to better match host bone, promoting load transfer while minimizing stress shielding and periprosthetic bone resorption. The outer layer of the femoral head features further reduced stiffness to absorb impact loads, thereby lowering contact stress and wear. These outer layers may also be engineered as a cartilage scaffold for gradual replacement by newly formed cartilage. Other mechanical and biological properties can be graded analogously according to their functional roles. As a design paradigm, functional grading maps key design variables onto physiological gradients in the proximal femur, such as the cortical–trabecular transition, regional load transfer, and distinctions between load-bearing and stress-shielded regions. These gradients reflect spatial variations in both mechanical demand and biological activity, with higher strain energy density in cortical regions and elevated remodeling activity in trabecular regions. Accordingly, mechanically dominant regions prioritize stiffness and initial stability, whereas biologically active regions benefit from increased porosity, permeability, and surface bioactivity to promote osseointegration and long-term adaptation. The proposed FG-HSIH concept shares features with existing functionally graded biomaterials and porous scaffold-based implants, which typically optimize individual properties such as stiffness or porosity [81,82]. In contrast, FG-HSIH represents a physiology-informed design paradigm in which implant properties collectively follow underlying gradients rather than targeting individual parameters. It adopts an integrated, spatially coordinated approach in which multiple interdependent properties—including load transfer, porosity/permeability, surface bioactivity, and degradation behavior—are tailored simultaneously across regions. This system-level design addresses the coupled mechanical and biological processes governing long-term implant performance. In addition to conventional mechanical parameters such as stiffness and strength, FG-HSIH covers a substantially broader design space by introducing a greater number of controllable variables, thereby providing much greater flexibility to satisfy diverse mechanical and biological requirements. In the next subsection, we show how key design parameters, including stiffness/strength, wear resistance, fatigue resistance, porosity/permeability, degradation rate, and surface bioactivity, can be tuned to mitigate the root causes of long-term implant failure. Although the present work focuses on long-term failure mechanisms, immediate postoperative stability must also be recognized as a fundamental prerequisite for successful implant performance. FG-HSIH designs must provide sufficient initial stiffness and fixation to satisfy this requirement, which serves as an important boundary condition on design variables such as porosity and degradation rate. It should also be noted that FG-HSIH design is inherently region-specific, with each region governed by its primary mechanical and biological requirements while accounting for secondary considerations. In particular, the implant region is designed to provide load-bearing capacity and structural stability, whereas the scaffold region is tailored to promote bone ingrowth and biological integration. Mechanistic design strategies and recent advances in FG-HSIH design Significant progress has been achieved in the design of FG-HSIH aimed at mitigating the root causes of long-term hip implant failure. Fig. 5 presents a schematic summary of literature-reported strategies that utilize controllable mechanical and biological properties to counteract key failure mechanisms. At the top level, FG-HSIH categorizes designable properties into mechanical (stiffness/strength, wear resistance, fatigue resistance) and biological (porosity/permeability, degradation rate, surface bioactivity) domains. These properties, in turn, modulate the principal failure drivers: stress shielding, surface wear/micromotion, and poor osseointegration. Importantly, the relationships illustrated in Fig. 5 are many-to-many rather than one-to-one. Design strategies correspond to multiple mechanical properties and failure mechanisms, and these interactions are represented using color coding rather than explicit mappings. For example, the mechanical properties highlighted in dark blue (top rounded boxes) influence multiple failure mechanisms indicated by the corresponding dark blue elliptical shapes at the bottom, illustrating their broad and overlapping effects. The schematic also highlights bidirectional coupling among mechanical and biological design variables, as well as between mechanical and biological failure modes, underscoring the interdependence of mechanical behavior and biological response in determining implant performance. Schematic summary of design strategies in FG-HSIH linking designable mechanical and biological properties to failure mitigation. Mechanical properties (stiffness/strength, wear resistance, fatigue resistance) and biological properties (porosity/permeability, degradation rate, surface bioactivity) are tuned to counteract dominant implant failure mechanisms—stress shielding, surface wear + micromotion, and poor osseointegration. Bidirectional arrows highlight the coupling among design variables and between mechanical and biological failure pathways. Using Fig. 5 as a roadmap, we review literature-reported strategies that leverage the designable properties of FG-HSIH to mitigate the root causes of long-term failure in conventional hip implants. Addressing stress shielding by matching stiffness Many studies [8,9,25,77,83,84] have investigated strategies to prevent stress shielding by tailoring the implant's stiffness to more closely match that of bone. Novel titanium alloys with reduced elastic moduli have shown particular promise. Ti 33.6Nb 4Sn, a β-type titanium alloy, exhibits an elastic modulus of approximately 40–60 GPa—substantially lower than that of conventional Ti 6Al 4V (∼110 GPa) and cobalt–chromium alloys (210–230 GPa), and closer to the modulus range of human cortical bone (10–30 GPa) [9,68,77]. Clinical and biomechanical evidence indicates that this modulus range reduces stress concentration and load bypass, thereby preserving proximal femoral bone mineral density and minimizing cortical thinning [84]. Reduced-modulus alloys have been associated with reduced stem migration and more physiological proximal load transfer compared with higher-modulus titanium alloys [9]. Additively manufactured porous stems represent another major advancement. Lattice structures and graded porosity allow local tuning of mechanical stiffness, improving strain transfer to adjacent bone. Porosity gradients in the range of 50–70% have been shown to achieve stiffness levels as low as 10–30 GPa, closely matching cortical bone and reducing stress shielding in animal and computational models [26]. Region-dependent lattice configurations within femoral stems can effectively reduce stress shielding while maintaining adequate mechanical support [85]. Optimized metal lattice scaffolds have shown elastic moduli 40–70% lower than solid counterparts, improving physiological load sharing [83]. Functionally graded material (FGM) designs have also been applied to create continuous stiffness transitions along the stem length. Longitudinal stiffness gradients have been shown in finite element models to mitigate stress shielding in low-load regions while reducing stress concentrations near anchorage sites [86]. Experimental evaluations confirm that graded-modulus stems restore strain distributions similar to those of intact femurs, promoting favorable remodeling patterns [67]. Alternative polymer-based materials, such as polyether ether ketone (PEEK), have been explored for their intrinsically low modulus (3–4 GPa). In sawbone models, PEEK stems have yielded higher strain energy density in the proximal femur than titanium stems, resulting in a reduced risk of proximal bone resorption [64]. Overall, evidence from these studies demonstrates that reducing stiffness mismatch—through low-modulus titanium alloys, porous or lattice structures, polymer composites, and functionally graded architectures—can effectively suppress stress shielding and help preserve periprosthetic bone health. Enhancing material wear resistance to minimize wear particle generation Reducing wear particle generation through improved material wear resistance is an essential design strategy for extending implant longevity and mitigating biologically driven failure modes. Quantitative studies highlight the strong dependence of wear behavior on material selection [75,76,[87], [88], [89]]. For example, highly cross-linked polyethylene (XLPE) liners exhibit wear rates of approximately 0.68 ± 0.11 mg/million cycles, compared to 24.97 ± 1.59 mg/million cycles for conventional ultra-high-molecular-weight polyethylene (UHMWPE), representing more than an order-of-magnitude reduction. In contrast, the choice of femoral head material (e.g., CoCrMo versus ceramic) has a comparatively minor effect on wear performance. These results indicate that material selection at the articulating interface is the dominant factor in minimizing wear particle generation. Recent research has focused on advanced bearing materials and surface treatments to further enhance wear resistance. Highly cross-linked polyethylene (HXLPE) and vitamin E-stabilized polyethylene liners have demonstrated up to 50–90 % lower volumetric wear compared to conventional polyethylene, significantly reducing debris production in total hip arthroplasty [75,76,87,90,91]. Similarly, ceramic-on-ceramic and ceramic-on-HXLPE pairings provide superior wear characteristics and lower particle reactivity compared with traditional metal-on-polyethylene interfaces [91]. Metallic femoral stems and modular junctions have also undergone wear-focused improvements. Nitriding, anodizing, and diamond-like carbon (DLC) coatings have been applied to titanium and cobalt–chromium alloys, yielding marked reductions in surface roughness and fretting corrosion at taper junctions [92,93]. DLC coatings, in particular, exhibit high hardness (2000–3000 HV) and low friction coefficients (<0.1), effectively limiting abrasive and adhesive wear under high cyclic loads. Surface texturing combined with hard coatings further decreases micromotion-induced wear at bone–implant interfaces while supporting bone cell attachment and osseointegration [11,94]. Additive manufacturing and hybrid material systems have also contributed to enhanced wear performance. Structurally optimized lattice stems distribute mechanical loads more uniformly, lowering the relative micromotion that drives wear at the stem–bone interface. Studies have demonstrated that porous titanium coatings combined with hydroxyapatite or bioactive glass not only facilitate osseointegration but also reduce local mechanical fretting, significantly limiting particle release [88,95]. These advancements enable the integration of wear-resistant materials and surface engineering strategies into implant design. By reducing wear debris generation at both articulating and non-articulating interfaces, these innovations lower the risk of inflammatory osteolysis and enhance long-term implant stability. Designing porosity, permeability, and surface bioactivity for improved osseointegration Porosity and permeability are critical for facilitating bone ingrowth and enabling nutrient and waste transport within the scaffold region. New bones within porous structures typically develop as fine trabecular networks rather than large, dense bone masses, highlighting the importance of matching pore architecture to the scale of bone ingrowth. In porous implants, pore size should therefore be designed in a graded manner, typically within the ranges of 100–500 μm that support cell migration, vascularization, and trabecular bone formation [96,97]. Porous architecture enhances interfacial fixation primarily through bone ingrowth and mechanical interlocking, which can be more effective than direct solid-to-solid contact. Surface bioactivity is equally important, as the implant surface directly influences its interaction with surrounding tissue. Incorporating bioactive coatings or materials in regions intended for bone integration promotes cellular attachment and bone growth. Recent advances in additive manufacturing have enabled precise control of internal architecture to customize both porosity and permeability in bone implants [[98], [99], [100]]. Titanium alloy scaffolds based on triply periodic minimal surface (TPMS) geometries fabricated by selective laser melting have demonstrated porosities of 50–80% and permeability levels that are tunable through pore topology, approaching the fluid transport characteristics of trabecular bone [98,99]. In vivo evaluations of TPMS-based structures have shown extensive bone ingrowth, reaching 60–70% of available pore volume within 8–12 weeks, and demonstrated mature lamellar bone spanning interconnected pores up to 500 μm [100]. These findings suggest that pore interconnectivity and architecture, rather than porosity alone, are key to supporting nutrient transport and functional osseointegration. Advances in surface bioactivity extend beyond conventional plasma-sprayed hydroxyapatite coatings. Recent research reports success with biomimetic calcium–phosphate coatings, silica-based bioactive glass layers, and ion-doped apatite coatings (e.g., strontium or zinc), which have shown improvements in osteoblast adhesion and accelerated early-stage mineralization [101,102]. Hydroxyapatite-coated porous titanium implants increased bone–implant contact by 30–40% within 4–6 weeks, while ion-doped coatings enhanced bone bridging and increased pull-out strength by 20–25% compared to uncoated titanium [103,104]. Nanostructured surface modifications, such as anodized titanium oxide nanotubes with diameters of 50–100 nm and femtosecond laser texturing, further increased expression of osteogenic markers (e.g., alkaline phosphatase and RUNX2) and promoted rapid matrix mineralization [103,104]. Emerging designs integrate graded structural porosity with surface bioactivity to enhance both mechanical integration and biological fixation. Finite element models of radially graded porous stems—with dense cores and outer scaffold regions (porosity up to 70%)—predict reductions in interfacial micromotion and improved load transfer patterns [25,105]. In vivo studies have shown that hydroxyapatite-coated titanium implants exhibit enhanced bone–implant contact and increased pull-out strength in animal models [106,107]. Although these features have yet to be combined in a single preclinical model, the converging evidence suggests that functionally graded stems with porous outer layers and bioactive coatings hold promise for reducing stress shielding while accelerating osseointegration. Controlling degradation rate for optimal osseointegration The ability to tune the degradation rate of biodegradable scaffolds is increasingly recognized as essential for synchronizing implant resorption with new bone formation. In FG-HSIH, degradation is not only governed by material selection but also by structural design. In particular, degradation is spatially controlled through region-specific architectures, where the scaffold region is designed to degrade progressively while the load-bearing implant region remains stable [108]. Gradients in porosity, strut thickness, and surface exposure can be used to tailor local degradation rates [109], enabling a controlled transition of load from the implant to regenerating bone over time. Contemporary research has made substantial strides by leveraging material chemistry, surface engineering, and macrostructure design to strike this critical balance. Recent studies have identified magnesium (Mg)-based alloys as the primary focus for osseointegrative implants, providing bone-matching mechanical moduli while enabling degradability at rates controllable between 0.02 and 0.31 mm/year—orders of magnitude slower than early prototypes—through alloy selection and processing innovations [79,110,111]. Notably, selective laser melting (SLM) has been harnessed to produce lattice structures of Mg, Zn, and Fe alloys [112]. By adjusting layer thickness and porosity, researchers have achieved both load‐bearing stiffness (40–45 GPa) and moderate degradation profiles (e.g. 1–3 mm/year for Zn), aligning temporal structural support with bone regeneration trajectories [112,113]. Longitudinal in vivo studies over 6–9 months in rabbit femur models have compared Mg-10Gd, Mg-4Y-3RE, and Mg-2Ag alloys—demonstrating that slower‐degrading alloys (e.g. containing Gd or Y) maintain implant morphology longer and preserve mechanical integrity, while still promoting mature bone integration with bone volume fraction (BV/TV) over 40% and bone-implant contact (BIC) above 50% [111,114]. Moreover, pre‐incubation of implants in autologous blood further enhanced BIC in fast-degrading Mg-2Ag at 9 months, suggesting that protein adsorption modulates early degradation kinetics and cell interaction at the interface [111]. Surface coatings and ion implantation strategies have emerged as powerful tools to slow and spatially regulate degradation. A poly‐β‐hydroxybutyrate (PHB) coating on AZ31 Mg alloy reduced the in vitro degradation rate by approximately fourfold, limiting early Mg2+ release and hemolysis, enhancing endothelial cell proliferation, and enabling programmed resorption aligned with tissue healing timelines [115,116]. Similarly, coating AZ91 alloy surfaces with chitosan/ZIF-8 metal–organic framework (MOF) nanoplates reduced the degradation current by approximately 80% and suppressed hydrogen evolution in simulated body fluid, demonstrating a robust barrier function capable of finely modulating the early stages of degradation [115]. Continuous plasma electrolytic oxidation (PEO) of WE43 Mg alloy wires produced a thin (8 μm) oxide/phosphate layer that dramatically improved corrosion resistance in vitro and preserved mechanical strength (>100 MPa after 96 h in simulated body fluid), while enabling pre-osteoblast attachment [117]. Together, these advances illustrate a multi-tiered approach to controlling degradation—through alloy composition (e.g., rare-earth element additions), additive manufacturing for tailored porosity and stress distribution, surface coatings (polymeric or MOF-based), and engineered oxide layers. These methods transform degradation from an unpredictable liability into a controllable design feature, ensuring gradual load transfer to regenerating bone and promoting reliable osseointegration. Mechanical–biological interdependences and trade-offs in FG-HSIH design As noted in the previous section, the designable properties and variables of FG-HSIH are interdependent; many are competing, such that improving or optimizing one parameter in isolation may compromise others. These interdependencies give rise to inherent trade-offs between mechanical attributes and the biological processes governing bone–implant integration. For example, increasing porosity to enhance osseointegration often reduces structural stiffness and may also accelerate degradation. Advancing FG-HSIH design therefore requires a comprehensive understanding of these interactions and the development of rigorous strategies to manage the resulting trade-offs. The network of these trade-offs is complex: some relationships are direct and evident, whereas others are indirect, subtle, or not yet fully understood. In this section, we analyze literature-reported trade-offs summarized in Fig. 6, where labels (A)–(F) denote the respective property pairs or groups. For each pair, we describe the underlying mechanisms, outline implications for FG-HSIH performance, and present selected studies demonstrating how these trade-offs have been addressed. It is important to note that a given trade-off may dominate a specific region of FG-HSIH but cannot be neglected in other regions, as its consequences often propagate across the whole device. For example, the trade-off between porosity/permeability and stiffness is primarily governed in the scaffold region, where increased porosity promotes bone ingrowth but reduces mechanical strength. However, excessive reduction in stiffness can alter global load transfer, increasing stress concentration or instability in the load-bearing implant region. This example highlights that trade-offs must be evaluated and optimized at the system level. (A)Stiffness & Strength vs Porosity & Permeability Stiffness & Strength vs Porosity & Permeability Conflicts among five key designable properties. Arrows labeled (A)–(F) indicate conflict pairs. As discussed in Section 3.2.3, increasing scaffold region porosity and permeability enhances bone ingrowth, vascularization, and nutrient transport. These gains, however, carry a mechanical penalty: porosity is inversely related to structural stiffness and strength. Excessive porosity can lead to large deformations, promote micromotion at the bone–implant interface, and elevate the risk of failure under physiological loading conditions [118,119]. Extensive efforts have therefore focused on resolving this conflict pair through designs that preserve transport while maintaining adequate load-bearing capacity. Triply periodic minimal surface (TPMS) architectures offer a promising solution to balance this trade-off. Recent studies [27,99,120] show that pore geometry, surface curvature, and porosity jointly govern scaffold elastic modulus and permeability, and that optimized TPMS designs can better match trabecular bone mechanics while preserving efficient mass-transport pathways. Experimental TPMS structures with porosity gradients or specially engineered “multi-functional pores” [120] have achieved compressive stiffness values within 3–6 GPa and permeability levels comparable to cancellous bone (10−9 to 10−8 m2). In vivo and computational studies further substantiate these findings. TPMS scaffolds with controlled curvature and porosity between 60 and 75% can achieve compressive strengths of 80–120 MPa and elastic moduli of 4–6 GPa, closely approximating those of trabecular bone while maintaining permeability in the 10−9 m2 range [99]. Scaffolds incorporating dense cores and porous outer layers are shown to distribute stress more uniformly than fully porous designs, effectively reducing stress concentrations and improving load transfer efficiency [118]. Functionally graded Ti-6Al-4V scaffolds are reported to support up to 65% bone ingrowth and the formation of mature lamellar bone within interconnected pores of approximately 400–600 μm, confirming both structural stability and biological fixation [121]. TPMS scaffolds optimized through isosurface offset adjustments are found to double fluid transport efficiency without compromising mechanical stiffness [122]. Collectively, these studies validate that optimized TPMS architectures can concurrently deliver bone-like stiffness, efficient mass transport, and robust osseointegration—critical attributes for advancing FG-HSIH design. (B)Stiffness & Strength vs Degradation Rate Stiffness & Strength vs Degradation Rate In the degradable scaffold region of FG-HSIH, stiffness and strength must remain above clinically relevant thresholds for a critical period—typically several months—to prevent micromotion and early mechanical failure, while the scaffold must ultimately resorb to restore native function. Faster degradation accelerates resorption but prematurely reduces effective stiffness and strength; conversely, slower degradation preserves mechanical integrity but may prolong foreign-body presence and maintain stress-transfer mismatch. This trade-off is governed by material class, scaffold architecture, and surface state. Design levers include alloying and composite formulation, crystallinity control, graded porosity and strut geometry, and graded or segmental coatings—each offering a route to engineer a stiffness–degradation trajectory that maintains early mechanical competence while enabling progressive load transfer to regenerating bone [123,124]. Degradable metallic scaffolds, such as Mg- and Zn-based systems, exhibit bone-like elastic moduli in the range of approximately 40–45 GPa [125,126], while their degradation rates can vary from about 0.02 to 0.31 mm/year for optimized Mg-based alloys and about 1–3 mm/year for Zn-based systems, depending on alloy composition and processing conditions [126,127]. Controlling crystallinity through thermo-mechanical processing stabilizes early-stage mechanical behavior by refining grain structure and reducing galvanic micro-cells, which lowers initial corrosion rates [128]. Architectures with radially or axially graded porosity concentrate slower-degrading, mechanically robust regions in load-bearing zones while permitting faster peripheral resorption, achieving both support and spatially adaptive degradation [129]. Adjustments in strut geometry, including tapered or thickened elements, further regulate how stiffness evolves during material loss [123]. Graded or segmental surface coatings—such as polymeric films, PEO layers, or corrosion-inhibiting bioactive coatings—reduce early corrosion currents by 50–80 % and modulate ion release [124]. Collectively, these strategies demonstrate how degradation can be transformed from an uncontrolled liability into a tunable design variable aligned with both mechanical stability and biological regeneration. (C)Fatigue vs Surface Bioactivity Fatigue vs Surface Bioactivity The implant neck and transition regions are subjected to repeated physiological loading while also requiring integration with the host bone. Therefore, designing implant surfaces to enhance bioactivity—such as through hydroxyapatite (HA), bioactive glass, or protein-functionalized coatings—can significantly improve early-stage osseointegration and cellular adhesion. However, these benefits often come at the expense of mechanical durability. Bioactive coatings tend to alter surface microstructure, potentially reducing fatigue strength, increasing brittleness, or creating delamination risks under cyclic loading. For instance, HA coatings are well-known for their high bioactivity but also exhibit poor fatigue resistance and weak bonding to metal substrates. HA coatings have been reported to reduce the fatigue strength of titanium-based substrates by approximately 20–50% [130,131]. Surface-functional structuring approaches for titanium and titanium alloys demonstrate that tuning micro/nano-topography and chemistry can enhance bioactivity while limiting fatigue penalties by controlling coating thickness and residual stresses [130]. Strategies that simultaneously improve biocompatibility and antibacterial performance emphasize multilayer or graded coatings that concentrate bioactive or antimicrobial phases at the surface while preserving a mechanically robust substrate, thereby mitigating fatigue degradation [132]. Optimizing composition, adhesion, and microstructure of bioactive coatings has been effective to balance osteoconductivity with fatigue resistance and to prevent coating delamination under cyclic loading [133]. Recent advancements in surface modification of additively manufactured metallic implants further show that combining roughened, bioactive surfaces in bone-contacting regions with mechanically optimized core structures can improve osseointegration without compromising overall fatigue performance [131]. (D)Wear Resistance vs Surface Bioactivity Wear Resistance vs Surface Bioactivity Roughened or bioactive surfaces—such as hydroxyapatite (HA), bioactive glass, or textured coatings—enhance bone bonding, cellular attachment, and osseointegration in bone-contacting regions. However, these same surface modifications can be detrimental in articulating zones, where implant–implant movement demands high wear resistance and minimal debris generation. Bioactive coatings often raise surface roughness, promoting osteogenic and antibacterial interactions but also increasing friction and wear. From a quantitative perspective, articulating implant surfaces typically require ultra-smooth finishes with surface roughness values below approximately Ra <0.05 μm, whereas bioactive or roughened surfaces designed to promote osseointegration commonly exhibit roughness in the range of Ra ∼1–10 μm. This substantial increase in surface roughness can elevate friction coefficients (typically from ∼0.05 to 0.1 to values exceeding ∼0.2) and accelerate wear, with typical wear rates in metal-on-polyethylene systems on the order of ∼1–10 mm3/year. Plasma-sprayed HA and TiO2 coatings, while improving cell adhesion and early integration, introduce micro-roughness that can elevate wear debris generation under articulating loading [131,134]. Thicker ceramic layers may crack or delaminate over time, risking particulate release [135]. Hard ceramic coatings offer wear resistance but may compromise integration. Coatings like Al2O3 or ZrN/TiSiN significantly improve wear resistance and reduce metal-ion release in metal-on-metal or metal-on-polyethylene articulations [134,136,137]. However, their relative bio-inertness limits osteo-conductivity, and they may not promote the same level of bone bonding as HA or bioactive glass coatings, especially in non-articulating regions [134,138]. (E)Degradation Rate vs Wear Resistance Degradation Rate vs Wear Resistance In conventional total hip replacements, degradable materials are not used at articulating interfaces because bearing surfaces must remain chemically stable, hard, and wear resistant. By contrast, in FG-HSIH designs that incorporate a biodegradable cartilage-mimicking layer [139,140] at the femoral head–acetabular interface, degradation rate and wear resistance become directly antagonistic. Materials and architectures engineered to resorb and be replaced by neo-cartilage necessarily lose hardness, cohesion, and surface smoothness over time, increasing third-body debris generation. Natural articular cartilage exhibits extremely low wear rates on the order of 0.01–0.1 mm3/year, whereas degradable or polymeric articulating materials may experience substantially higher wear rates approaching 1–10 mm3/year, particularly as degradation progresses. In parallel, biodegradable materials designed for resorption typically exhibit degradation rates on the order of 0.1–1 mm/year, leading to progressive loss of mechanical integrity and surface smoothness. Conversely, surfaces optimized for wear resistance require chemically stable, non-degrading layers with high hardness and low friction—properties incompatible with controlled resorption. Thus, for a biodegradable cartilage-mimicking articulating layer, enhancing degradability intrinsically diminishes long-term wear durability and elevates debris-driven inflammation and osteolysis risk. (F)Degradation Rate vs Surface Bioactivity Degradation Rate vs Surface Bioactivity Surface bioactivity in the scaffold region of FG-HSIH depends on controlled interfacial reactivity that initiates apatite nucleation and drives osteogenic signaling. Moderate dissolution and ion release (e.g., Ca2+, PO43−, Si, Sr) form a bone-like interphase and stimulate cellular activity, a process well documented for hydroxyapatite and bioactive glasses via dissolution–reprecipitation of an apatite layer [141,142]. Ion release within the range of approximately 0.1–1 mM is generally associated with favorable osteogenic responses, whereas excessive concentrations exceeding 2–5 mM may disrupt cellular activity and impair tissue formation. If the surface is too inert (minimal dissolution), nucleation and cell responses are attenuated; if dissolution or corrosion is excessive, the interface destabilizes, local chemistry is perturbed (e.g., pH rise or hydrogen evolution for Mg). In particular, local pH values increasing beyond 8–9 from the physiological range of 7.2–7.6 can negatively affect cell viability and protein activity, while rapid degradation on the order of >1 mm/year may further compromise interfacial stability. Collectively, these effects lead to particulate release and undermine osseointegration [116,143]. It should be noted that the conflict pairs discussed above capture only direct trade-offs and are not exhaustive; indirect and higher-order couplings also occur, meaning the effects of these trade-offs may extend beyond each individual pair. For example, increased porosity and permeability enlarge exposed surface area and fluid access in scaffold regions, accelerating degradation. This, in turn, compounds mechanical loss—reducing effective stiffness and strength—whether driven primarily by porosity, by degradation, or by their interaction. Our aim is not to catalog every possible conflict, but to underscore the interdependence of these properties and the inherent trade-offs they impose. These interdependent and competing property requirements present a fundamental challenge in FG-HSIH design. Conventional trial-and-error approaches are inefficient due to the high-dimensional and coupled design space. This motivates the need for a simulation-guided, multi-objective design framework capable of systematically balancing these trade-offs. Multiphysics simulation framework for optimal FG-HSIH design Recent studies have begun to formalize the trade-offs outlined in Section 4 within computational optimization frameworks. For instance, density-mapped functionally graded lattice designs and topology-based approaches have been proposed to simultaneously tailor stiffness distribution and structural performance across the implant. These methods demonstrate the potential of integrating mechanical and biological criteria within a unified quantitative framework [23,24]. A multiphysics simulation-guided design approach provides a more effective alternative to trial-and-error methods. By predicting interactions among mechanical, biological, transport, and degradation processes prior to fabrication, such frameworks enable systematic optimization of FG-HSIH designs under clinically relevant conditions. In this context, the proposed framework below can be viewed as a conceptual extension of emerging quantitative optimization strategies, integrating multiple design variables within a clinically relevant multiphysics setting. Integrated multiphysics simulation and optimization framework Fig. 7 presents an integrated, simulation-guided design workflow for FG-HSIH that integrates patient-specific data, high-fidelity computational modeling, and multi-objective optimization in an iterative loop, informed and inspired by recent advances. Within the proposed multiphysics–mechanobiology framework, the primary state variables can be grouped into four interacting categories: (i) mechanical stimulus, typically represented by strain, stress, or strain energy density; (ii) tissue state, including local bone density, microstructural phenotype, and biological activity; (iii) interface integrity, reflecting fixation stability, micromotion, and bone–implant contact; and (iv) scaffold or implant state, encompassing degradation, damage accumulation, and evolving load-sharing capacity. These variables collectively describe the evolving mechanical and biological environment governing implant performance and periprosthetic adaptation. Importantly, these state variables are coupled through bidirectional feedback loops, rather than one-way causal relationships. Mechanical loading influences tissue differentiation and remodeling, while biological adaptation and degradation progressively modify local stiffness, load transfer, and interface stability. Changes in interface integrity, in turn, alter local mechanical stimuli and boundary conditions. Functional grading therefore interacts dynamically with both mechanics and biology, reinforcing the need for feedback-aware modeling rather than static optimization. Within the proposed simulation framework, immediate postoperative stability is treated as a fundamental design constraint that depends strongly on host bone quality and surgical factors. Integrated multiphysics simulation and optimization framework for FG-HSIH design. The workflow integrates patient-specific data acquisition, pre-design analysis, integrated mechanical and biological design, multiphysics simulation, and multi-objective optimization. An iterative feedback loop refines design parameters until weighted multi-objective performance targets are achieved. Several components are already available or under active development; however, full end-to-end integration at this level remains aspirational. Progress in their development is reviewed in the following subsection. Recent advances and remaining gaps in the Simulation–Optimization framework Only those advances that directly align with the simulation–optimization framework illustrated in Fig. 7—and that directly address the root causes of long-term failure in conventional implants—are reviewed in this section. These advances fall into four interconnected fronts: (1) image-based evaluation of bone mechanical competence at the fracture site, yielding patient-specific geometry and quantitative measures of bone quantity and quality for personalized design; (2) finite-element-based mechanical analysis and design, translating these inputs into architectures that control load transfer, stiffness gradients, and fatigue risk; (3) biological simulation of osseointegration and scaffold degradation, capturing time-dependent tissue deposition and material resorption to close the mechanobiological loop; and (4) multiphysics simulation coupled with multi-objective optimization, integrating mechanics, transport, and degradation to negotiate competing requirements and identify Pareto-efficient solutions. Although these advances represent genuine conceptual and technical leaps, none yet achieved full end-to-end integration, and substantial gaps remain between current capabilities and the comprehensive framework envisioned in Section 5.1. Image-based assessment of bone mechanical competence at the fracture site Recent work [144] shows that 3D finite-element models (FEM) reconstructed from routine 2D DXA scans can outperform areal bone mineral density in predicting incident hip fractures in population cohorts. However, despite this improvement, DXA-based FEM remains insufficient for patient-specific FG-HSIH design, as it lacks the geometric and material detail required for localized mechanical assessment. In contrast, QCT-derived FEM provides true volumetric information, enabling separation of cortical and trabecular compartments, tracking of cortical thinning, and—critically—empirical density–modulus and density–strength mappings that support voxel- or region-wise estimation of apparent elastic properties and yield behavior [145,146]. As a result, QCT-based FEM represents a major advance in the noninvasive assessment of femoral stiffness and strength. A substantial body of literature—particularly comprehensive reviews—has already addressed the use of QCT-derived FEM for fracture risk evaluation [[147], [148], [149]]; these topics are not reiterated here. However, QCT-derived FEM treats mineral content as the primary determinant of bone mechanics and typically does not explicitly account for the organic matrix and water—key regulators of toughness, post-yield behavior, and time-dependent responses. As a result, QCT-derived FEM can underestimate strength in regions with collagen-rich matrix, particularly under tension-dominated loading, where matrix quality—not just mineral content—governs failure. Dual-energy CT (DECT) addresses this gap by decomposing bone into basis materials [150,151]—mineral, collagen protein, and water—enabling composition-aware constitutive models rather than single-parameter (density-only) fits. Incorporating these constituents provides a sound foundation for applying established composite-material theories to bone, supporting explanations of orthotropic elasticity, tension–compression asymmetry, and damage evolution, and thereby strengthening patient-specific FG-HSIH design. FEA-guided mechanical design of FG-HSIH Section 5.2.1 reviewed advances in image-based assessment of bone mechanical competence, an important factor in the long-term success of total hip arthroplasty. In this section, we focus on recent advances in applying finite element analysis (FEA) to address the mechanical root causes of long-term failure, primarily related to bone–implant interactions, including (i) instability and micromotion at the bone–implant interface, (ii) abnormal contact mechanics that drive wear, edge loading, and liner damage, and (iii) maladaptive load transfer (stress shielding) that promotes late loosening. Primary stability is essential for osseointegration; when interface micromotion exceeds modest thresholds, fibrous tissue forms and long-term fixation is compromised. FEA converts press-fit “rules of thumb” into actionable design levers. By explicitly modeling interference fit/under-reaming, cavity geometry and reaming depth, surface texture/porosity, and physiologic, activity-dependent loads, subject-specific FE simulations can be used to iteratively refine designs—minimizing peak interface slip, keeping micromotion within osseointegration-friendly thresholds, and avoiding local bone over-strain or plasticity that would compromise fixation. Recent studies show how adjusting reaming depth and interference fit improves cup fixation while controlling host-bone strain; FEA exposes the trade-off and identifies optima for a given bone quality and load set [152,153]. Predictive validity has improved as patient-specific FE predictions of early cup stability have been corroborated against in-vivo radiostereometric analysis (RSA) migration, supporting the use of physiological loading and detailed contact in the primary-stability design loop [154]. Standardized computational protocols and evidence-based modeling guidelines now define workflows for cementless stems—linking bone quality, friction and contact assumptions, and boundary conditions to migration risk—allowing engineers to set press-fit and surface parameters that reliably promote osseointegration rather than fibrous fixation [155,156]. Simulation-guided FG-HSIH design supported by FEA treats stress shielding as a design objective rather than relying on postoperative remedies by (i) quantifying load transfer using patient-specific femur–implant models under activity-based load spectra, (ii) tuning component stiffness—via materials, geometry, and porosity/lattice/TPMS grading—to preserve proximal mechanical stimuli, and (iii) embedding strength and fatigue checks to ensure that stiffness reductions do not compromise long-term durability. Recent work illustrates how FEA enables mechanically informed design of FG-HSIH. Density-based topology optimization of homogenized lattice regions in patient-specific stems can systematically reduce stress shielding while satisfying strength constraints [157], demonstrating how FEA identifies where stiffness can be safely lowered. Material substitution analyses—such as comparing CFR-PEEK with Ti-6Al-4V—show that reducing stem modulus decreases proximal stress shielding and improves load sharing to bone [158]. FEA also evaluates geometric strategies: anatomically curved stems and compliant groove or rib features lessen stress shielding relative to conventional straight designs [159]. These stiffness-lowering strategies must be balanced against fixation requirements; FEA is essential here, as it quantifies the resulting increases in interface stresses and maps micromotion and interface strain fields to ensure osseointegration is not compromised [67]. Modern pipelines extend this analysis across patient-specific load spectra, running multi-activity simulations (walking, stair ascent/descent, sit-to-stand, etc.) to characterize regional strain energy and the magnitude of stress shielding under realistic conditions [160]. Fatigue and endurance analyses are then layered on top to confirm that graded or lattice regions retain adequate safety factors over the implant's lifetime [161]. Together, these capabilities establish FEA as the central tool for multi-objective tuning of material selection, spatial grading, microarchitecture, and stem positioning in FG-HSIH—maintaining proximal bone stimulation while safeguarding fixation stability and long-term structural reliability. Biological simulation of implant osseointegration and scaffold degradation Biological simulation is currently the least mature—yet potentially the most transformative—component of the FG-HSIH design framework. Recent mechanobiological models now begin to close the loop between mechanical environment, tissue differentiation, scaffold degradation, and long-term fixation. Several in silico models [162,163] that couple FEA mechanical simulation with agent-based or mechanoregulation algorithms demonstrate that scaffold-supported bone regeneration can be predicted using established mechano-biological rules, and that scaffold architecture (e.g., pore size, spatial gradients, stiffness) can be treated as an explicit design variable for maximizing regenerated bone volume over time. These models reproduce experimentally observed spatial and temporal patterns of bone formation by capturing how local strains, fluid flow, and mechanical stimuli regulate cell recruitment, differentiation, matrix deposition, and remodeling [164]. Recent extensions of this approach to functionally graded scaffolds [165] show how axial or radial porosity gradients modulate both regenerative performance and structural competence, while a broader examination of mechanobiological healing models [166] reinforce the translational potential of these simulation models. These advances provide an initial foundation for designing the scaffold region of FG-HSIH by showing how biological simulation can inform architectural and degradation strategies in a mechanistically grounded manner. Parallel progress targets hip-specific osseointegration and interface biology. Finite-element models for cementless stems increasingly move beyond purely contact-based representations by incorporating material laws or mechanoregulatory algorithms for interfacial bone formation, allowing simulation of early migration and long-term stability as evolving biological processes rather than static boundary conditions [155,167,168]. Mechanobiology-based FE studies have also been used to predict spatially evolving bone ingrowth into porous or functionally graded hip stems, mapping local mechanical stimuli around the lattice or porous coating to tissue differentiation patterns and ingrowth extent [169,170]. These developments demonstrate that mechanobiological simulation can inform scaffold architecture, surface design, and fixation strategy in a manner highly compatible with FG-HSIH concepts. Multiphysics simulation and multi-objective design optimization Recent efforts have begun to integrate FG-HSIH design into multiphysics simulation and multi-objective optimization frameworks, although such approaches remain at an early stage. Multiphysics models have been developed to couple mechanical response with biological processes, particularly through mechanobiological simulations that link local strain and interstitial fluid flow to tissue differentiation and bone ingrowth [171,172]. In parallel, multi-objective optimization methods—based on topology optimization, density grading, and lattice design—have been increasingly applied to balance competing requirements such as stiffness matching, permeability, and structural integrity in porous or graded implants [[173], [174], [175]]. These progresses demonstrate the feasibility of integrating mechanical and biological criteria within a unified computational framework, enabling systematic exploration of high-dimensional design spaces beyond conventional trial-and-error strategies. However, most existing studies remain limited to partial coupling (e.g., mechanics with simplified biological rules or degradation models), idealized geometries, or single-scale formulations, and thus fall short of representing the full spatial and temporal complexity required for patient-specific FG-HSIH design. Key missing components and outstanding challenges in realizing the integrated framework A critical assessment of existing multiphysics and mechanobiological studies, as reviewed in Section 5.2 and evaluated against the integrated framework outlined in Section 5.1 (Fig. 7), reveals several key gaps that hinder the realization of FG-HSIH design. Current computational approaches vary widely in modeling scope and validation strategy, often focusing on mechanoregulation or remodeling under idealized conditions, with limited representation of evolving interface mechanics, long-term cyclic loading, and degradation-induced changes in load sharing—thereby only partially capturing the coupled mechanical–biological–degradation interactions required in the integrated framework. Validation is frequently restricted to qualitative trends or short-term data, whereas the framework calls for longitudinal, quantitatively validated predictions linked to clinically relevant outcomes. In contrast, experimental and preclinical studies emphasize biological response and osseointegration but often lack systematic control of mechanical boundary conditions and spatially graded material properties, preventing direct correspondence with model inputs and outputs defined in the framework. These discrepancies highlight a fundamental disconnect between model components and experimental evidence across scales. More specifically, several critical elements of the integrated framework remain underdeveloped or absent. First, full multiphysics coupling is lacking: existing models rarely integrate mechanics, transport, biological processes, and degradation within a unified, time-dependent simulation architecture, nor do they incorporate patient-specific biological inputs required for predictive design. Second, the optimization layer remains incomplete, as current approaches seldom enable biologically driven, multi-objective optimization that links graded design variables to both mechanical performance and biological outcomes. Third, physiological grounding and validation are insufficient, with limited integration of in vivo data and a lack of consistent mapping between model predictions and clinically measurable endpoints such as fixation stability, remodeling progression, and failure risk. Fourth, the translation pathway—from simulation to manufacturing and clinical deployment—remains fragmented, with unresolved challenges in implementing spatially graded designs under constraints of manufacturing reproducibility, quality assurance, and regulatory approval. Fifth, from a translational perspective, the clinical implementation of FG-HSIH introduces additional regulatory considerations, particularly due to their multi-material and functionally graded nature. Hybrid systems that combine permanent load-bearing components with biodegradable or bioactive regions must satisfy stringent requirements for mechanical reliability, controlled degradation, and long-term safety [176]. The incorporation of patient-specific designs and spatially varying properties increases the complexity of validation and standardization, thereby posing additional challenges for regulatory approval. These gaps indicate that several core components of the framework illustrated in Fig. 7—namely multiphysics coupling, biologically informed optimization, cross-scale validation, and translational integration—remain underdeveloped, with clinically meaningful validation linking graded design variables to long-term fixation, remodeling, and failure risk still lacking. Consequently, the practical value of the framework depends on its alignment with clinically relevant conditions, as addressed in the following section through the definition of clinical indications and the mapping of failure mechanisms to FG-HSIH design strategies. Clinical–design synthesis and application of FG-HSIH This section integrates clinical context with design synthesis by first defining indication-dependent boundary conditions for FG-HSIH application and then mapping major total hip replacement (THR) failure modes to corresponding graded design strategies. Clinical indications and boundary conditions for FG-HSIH application Consistent with the framework outlined above, FG-HSIH application must be defined within indication-dependent clinical boundary conditions. Patients most likely to benefit are those at elevated risk of stress-shielding–driven bone loss, compromised bone quality, or challenging load-transfer conditions in which monolithic stems amplify mechanical mismatch. Examples include selected primary THR cases in elderly or osteoporotic patients, as well as revision scenarios in which preservation of remaining femoral bone stock is critical and improving proximal load transfer and interface stability is a priority [177,178]. Conversely, FG-HSIH complexity may be difficult to justify in lower-risk primary cases with good bone quality and predictable fixation, or in situations where workflow constraints, manufacturing lead time, or regulatory burden outweigh the expected benefit. Boundary conditions that should explicitly temper FG-HSIH adoption include limited capacity for patient-specific planning, uncertain host biology (e.g., systemic conditions that impair osseointegration), and cases in which infection risk or soft-tissue compromise dominates outcomes [179,180]. These considerations support a pragmatic near-term translational pathway that emphasizes semi-standardized, regionally graded designs for defined indications, while reserving fully patient-specific grading for cases in which incremental benefit is clinically meaningful. From a modeling and translational perspective, it is also important to recognize that many existing mechanobiological models were originally developed for non-load-bearing bone regeneration contexts, such as fracture healing or tissue-engineered scaffolds operating in low-stress environments [181,182]. Direct transfer of these models to total hip replacement (THR) applications should therefore be approached with caution. In load-bearing THR scenarios, high cyclic stresses, evolving boundary conditions, and long-term fixation requirements introduce additional complexities that are not adequately captured by models calibrated for regenerative settings. Consequently, while such frameworks provide valuable qualitative insight, their quantitative predictive capability for long-term THR performance remains limited without further validation and adaptation. In light of these limitations, the functional grading framework synthesized in this review is best interpreted as a physiology-informed design logic rather than a finalized prescription of spatially resolved material parameters. Although representative quantitative ranges for stiffness, porosity, and interface-related targets have been reported in the literature [96,183], current evidence remains insufficient to define universally applicable grading functions across all anatomical regions, patient populations, and surgical scenarios. Accordingly, the primary value of functional grading lies in its ability to constrain and guide the design space using established biomechanical and biological gradients, while retaining flexibility for patient-specific adaptation and future quantitative refinement as imaging, mechanobiological modeling, and clinical validation continue to mature. While patient-specific functional grading represents an attractive long-term objective, its practical implementation must be considered within the constraints of clinical workflow, cost, and scalability. Image acquisition, segmentation, design optimization, and manufacturing must be integrated into timeframes compatible with surgical planning, and the added complexity of patient-specific grading may not be justified for all clinical indications. Within these clinical and practical boundary conditions, the value of FG-HSIH ultimately depends on how effectively graded design strategies can be aligned with specific failure mechanisms and functional demands. The following section synthesizes these relationships by mapping major THR failure modes to corresponding FG-HSIH design levers. Mapping of THR failure modes to FG-HSIH design levers To provide a concise clinical–design overview, Table 1 summarizes the major long-term failure modes of total hip replacement and maps them to their dominant mechanisms, design-relevant root causes, actionable FG-HSIH design levers, and representative validation endpoints. Table 1Linking major THR failure modes to mechanisms, design levers, and validation endpoints.Table 1Major THR failure modeDominant mechanismsDesign-relevant root causesActionable FG-HSIH design leversRepresentative validation endpointsAseptic looseningStress shielding; wear-particle–induced osteolysis; mechanically driven bone resorptionStiffness mismatch; non-physiological load transfer; inadequate interface stabilitySpatial grading of stiffness; proximal porosity/permeability control; surface bioactivity tuningPeriprosthetic bone density change; micromotion; implant migration; interface shear stabilityPeriprosthetic fractureLocalized bone loss; stress concentration; reduced structural reserveExcessive stress shielding; abrupt stiffness transitions; weakened cortical supportGradual stiffness gradients; site-specific reinforcement near high-stress regionsStrain distribution; fracture risk indices; simulated fall or impact responseImplant fatigue failureHigh cyclic stresses; load redistribution due to bone lossStress concentration; long-term stiffness mismatch; degradation-induced load shiftsDistal stiffness tuning; fatigue-aware grading; degradation-informed designCyclic fatigue life; stress amplitude evolution; damage accumulation metricsDelayed or poor osseointegrationInadequate biological integration; interface micromotionInsufficient porosity/permeability; limited surface bioactivity; early instabilityProximal graded porosity; bioactive surface patterning; interface stiffness controlBone–implant contact ratio; ingrowth depth; early fixation stability Linking major THR failure modes to mechanisms, design levers, and validation endpoints. Together, these clinically observed failure modes and their underlying biomechanical and biological root causes highlight the need for implant design strategies that move beyond uniform material properties toward spatially and functionally tailored solutions. Conclusion Long-term complications such as aseptic loosening, periprosthetic fracture, wear-induced osteolysis, and stress shielding continue to limit the durability of conventional hip implants. This review highlights that these failures arise from a persistent mechanical–biological mismatch that no single-material implant can resolve. Functionally graded hip scaffold–implant hybrids (FG-HSIH) offer a compelling solution by enabling spatially tailored stiffness, porosity, degradation behavior, and bioactivity that better replicate the gradients inherent to healthy bone. A key contribution of this review is the integration of clinical, biomechanical, biological, materials, and computational perspectives into a unified simulation-guided FG-HSIH design paradigm. We synthesize advances in patient-specific mechanical assessment, finite-element–based mechanical optimization, mechanobiological modeling of osseointegration, and emerging multiphysics and multi-objective optimization frameworks. These advances outline the technical foundation required for next-generation graded hip implants. However, the review also identifies several foundational gaps that currently prevent realization of the integrated design framework proposed in Fig. 7. These include the absence of fully coupled degradation–mechanobiology simulations for hip implants, the lack of time-resolved co-simulation across mechanics, transport, biology, and degradation, the absence of patient-specific biological factors in implant design, and the limited use of biological performance as a primary design objective. Moreover, end-to-end validation pipelines and physiologically grounded benchmarks for spatial grading are still lacking, and no unified computational platform exists to execute the full design loop. By defining these gaps and integrating scattered advances into a coherent roadmap, this review provides a timely conceptual foundation for developing FG-HSIH that are mechanically robust, biologically integrative, and clinically durable. Future progress will require coordinated innovation across computational biomechanics, materials engineering, image-based modeling, and clinical orthopedics. With such interdisciplinary efforts, simulation-guided design has the potential to transform FG-HSIH from conceptual constructs into clinically deployable, personalized hip reconstruction solutions. Author statement Y.L. – Fund acquisition, Project administration, Investigation, Conceptualization, Writing – original draft, Writing - review & editing. T.T. – Writing - review & editing. I.P. – Writing - review & editing. Funding The author gratefully acknowledges the support of the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant, and the University of Manitoba through the Ignite Fund. Declaration of generative AI During the preparation of this work, the authors used ChatGPT (OpenAI) to assist with language refinement and improvement of clarity. After using this tool, the authors carefully reviewed and edited the content as needed and take full responsibility for the content of the published article. Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. References